Histopathology‐validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo‐progression in glioblastoma-Reference-Cited by-同舟云学术

Histopathology‐validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo‐progression in glioblastoma

Published:2020-03-04 Issue:11 Volume:126 Page:2625-2636
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Akbari Hamed¹²^ORCID,Rathore Saima¹²,Bakas Spyridon¹²³,Nasrallah MacLean P.³,Shukla Gaurav¹²⁴⁵,Mamourian Elizabeth¹²,Rozycki Martin¹²,Bagley Stephen J.⁶^ORCID,Rudie Jeffrey D.²,Flanders Adam E.⁷,Dicker Adam P.⁸,Desai Arati S.⁶,O’Rourke Donald M.⁹,Brem Steven⁹,Lustig Robert⁴,Mohan Suyash²,Wolf Ronald L.²,Bilello Michel¹²,Martinez‐Lage Maria¹⁰,Davatzikos Christos¹²

Affiliation:

1. Center for Biomedical Image Computing and Analytics University of Pennsylvania Philadelphia Pennsylvania

2. Department of Radiology Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania

3. Department of Pathology and Laboratory Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania

4. Department of Radiation Oncology Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania

5. Helen F. Graham Cancer Center and Research Institute ChristianaCare Newark Delaware

6. Department of Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania

7. Department of Radiology Thomas Jefferson University Hospital Philadelphia Pennsylvania

8. Department of Radiation Oncology Sidney Kimmel Medical College and Cancer Center Thomas Jefferson University Philadelphia Pennsylvania

9. Department of Neurosurgery Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania

10. Department of Pathology Massachusetts General Hospital Harvard Medical School Boston Massachusetts

Funder

National Institutes of Health

University of Pennsylvania

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32790

Reference50 articles.

1. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014

2. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

3. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

4. A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

5. Response criteria for phase II studies of supratentorial malignant glioma.

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence for response prediction and personalisation in radiation oncology;Strahlentherapie und Onkologie;2024-08-30

2. A review on the applications of artificial intelligence and big data for glioblastoma multiforme management;Egyptian Journal of Neurosurgery;2024-07-29

3. CFINet: Cross-Modality MRI Feature Interaction Network for Pseudoprogression Prediction of Glioblastoma;Journal of Computational Biology;2024-07-08

4. Deep learning-based deformable image registration with bilateral pyramid to align pre-operative and follow-up magnetic resonance imaging (MRI) scans;Quantitative Imaging in Medicine and Surgery;2024-07

5. Augmented surgical decision-making for glioblastoma: integrating AI tools into education and practice;Frontiers in Neurology;2024-06-07